Lipids and Lipid Derivatives
Medchemexpress LLC Vosoritide acetate | 1480724-61-5 | CB15508225 | 99.96% | 4162.78 | 10 MG
Vosoritide acetate | 1480724-61-5 | CB15508225 | 99.96% | 4162.78 | 10 MG
Apexbio Technology LLC Bradykinin (acetate) 6846-03-3 10mg
Bradykinin acetate (CAS 6846-03-3) is a peptide agonist targeting G protein-coupled B1 and B2 receptors It is designed to activate bradykinin receptors thereby modulating inflammatory responses vascular tone and endothelial signaling pathways Bradykinin acetate exerts its biological activity primarily through endothelium-dependent release of nitric oxide and prostacyclin leading to vasodilation Receptor activation also triggers non-vascular smooth muscle contraction increases vascular permeability and mediates pain signaling pathways Based on these pharmacological properties Bradykinin acetate holds research potential in studies of inflammation pain mechanisms and endothelial cell signaling
Medchemexpress LLC Bradykinin acetate | 6846-03-3 | 99.58% | 1060.21 (free base) | 50 MG
Bradykinin acetate | 6846-03-3 | 99.58% | 1060.21 (free base) | 50 MG
Medchemexpress LLC Iso-VQA-ACC acetate | 99.48% | 625.63 (free base) | 50 MG
Iso-VQA-ACC acetate is a substrate for constitutive proteasome, making it a valuable tool for studying proteasome-related pathways. This compound targets the proteasome and is relevant for research in metabolic enzymes and proteases.
- Substrate for constitutive proteasome
- Targets proteasome pathway
- Molecular formula: C29H35N7O9.xC2H4O2
- Molecular weight: 625.63 (free base)
- Appearance: white to off-white solid
- Purity: 99.48% by HPLC
Selleck Chemical LLC Geranyl acetate S5091-25ul
Geranyl acetate (Geraniol acetate Geranyl ethanoate) is a natural organic compound that is used primarily as a component of perfumes for creams and soaps and as a flavoring ingredient Geranyl acetate exhibits anti-cancer effects by inducing cell apoptosis
Hampton Research HR2-406-13/Detergent Screen #13 (B1), 0.5 ml - n-Tetradecyl-B-D-maltoside
HR2-406-13/Detergent Screen #13 (B1), 0.5 ml - n-Tetradecyl-B-D-maltoside. Please note items from this supplier are non-returnable.
Medchemexpress LLC Phenyl acetate | 122-79-2 | 99.7% | 1 ML
Phenyl acetate is an endogenous metabolite and a metabolite of 2-phenylethylamine, found in urine. It plays a role in regulating glutamine metabolism and has been investigated as a potential detection index for certain diseases, including depression. This product is supplied as a high-purity liquid.
- Endogenous metabolite
- Metabolite of 2-phenylethylamine
- Regulates glutamine metabolism
- Potential detection index for diseases like depression
- Can block glutaminolysis in lung cancer cell lines in vitro
- Colorless to light yellow liquid appearance
- High purity of 99.7%
Indofine Chemical 7-AMINO-4-METHYLCOUMARIN, Flavonoid & Coumarins, 26093-31-2, 98+%, 250 mg
7-AMINO-4-METHYLCOUMARIN, Flavonoid & Coumarins, 26093-31-2, 98+%, 250 mg
Sigma Aldrich Fine Chemicals Biosciences Retinyl Palmitate | 79-81-2 | MFCD00019414 | 1g
Retinyl Palmitate | Purity: 90% | Mol Wt: 524.86 | 79-81-2 | MFCD00019414 | 1g
Medchemexpress LLC Alarelin acetate | 79561-22-1 | MFCD00167542 | 1287.42 | C60H86N16O16 | 10 MG
Alarelin acetate is a synthetic gonadotropin-releasing hormone (GnRH) agonist peptide supplied as a dry powder for research applications. It targets the GnRH receptor and is intended for laboratory and preclinical use; not for human or clinical administration.
- Synthetic gonadotropin-releasing hormone (GnRH) agonist peptide.
- Provided as a powder suitable for storage and formulation.
- CAS number 79561-22-1 for unambiguous identification.
- Molecular weight 1287.42 g/mol (manufacturer reported).
- Storage: sealed, away from moisture; powder -80°C for 2 years or -20°C for 1 year.
- Intended for research use only; not for clinical or therapeutic use.
Apexbio Technology LLC DEGARELIX-ACETATE-50MG
Degarelix acetate (CAS No 934016-19-0) is a gonadotropin-releasing hormone (GnRH) antagonist used in biomedical research primarily for its role in androgen deprivation therapy Originating from synthetic peptides it functions by binding to GnRH receptors in the anterior pituitary gland effectively decreasing the release of luteinizing hormone and subsequently reducing testosterone production Its in vitro activity typically ranges from the nanomolar to low micromolar concentration Degarelix acetate is commonly applied in cell models and animal studies to investigate prostate cancer treatment and it is also used in drug screening for hormonal therapies Experimental concentrations typically depend on the specific research design offering flexibility in application across various studies